Moreover, using a CML multidrug resistance (MDR)/Imatinib resistant cell line (Lucena) and CML patients’ samples we address the relationship of STATIP1 and STAT3 in IM resistance. This evidence concerns the gene ELP2 and chronic myelogenous leukemia, BCR-ABL1 positive.